ArticlePharmacoEconomics1998

Cost-effectiveness analysis of ramipril in heart failure after myocardial infarction. Economic evaluation of the Acute Infarction Ramipril Efficacy (AIRE) study for Germany from the perspective of Statutory Health Insurance.

P K Schädlich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.